XOMA Royalty Corporation (XOMA)
- Previous Close
23.96 - Open
23.72 - Bid --
- Ask 23.94 x 100
- Day's Range
22.91 - 23.72 - 52 Week Range
18.35 - 35.00 - Volume
15,585 - Avg. Volume
26,731 - Market Cap (intraday)
275.395M - Beta (5Y Monthly) 0.90
- PE Ratio (TTM)
-- - EPS (TTM)
-1.65 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield 2.16 (7.99%)
- Ex-Dividend Date Jan 3, 2025
- 1y Target Est
64.67
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
www.xoma.comRecent News: XOMA
View More
Performance Overview: XOMA
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XOMA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XOMA
View MoreValuation Measures
Market Cap
275.39M
Enterprise Value
289.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
26.38
Price/Book (mrq)
3.36
Enterprise Value/Revenue
28.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-48.52%
Return on Assets (ttm)
-9.98%
Return on Equity (ttm)
-16.20%
Revenue (ttm)
28.49M
Net Income Avi to Common (ttm)
-19.29M
Diluted EPS (ttm)
-1.65
Balance Sheet and Cash Flow
Total Cash (mrq)
105.18M
Total Debt/Equity (mrq)
145.50%
Levered Free Cash Flow (ttm)
-25.34M
Research Analysis: XOMA
View MoreResearch Reports: XOMA
View MoreDaily – Vickers Top Buyers & Sellers for 01/29/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/06/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/28/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/19/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.